Q4 Aktie

Q4 für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A3DLU3 / ISIN: CA74738R1047

<
Kurse + Charts + Realtime
Kurs + Chart
Börsenplätze
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
26.08.2025 22:25:03

Electromed Posts 17% Gain in Fiscal Q4

Electromed (NYSEMKT:ELMD), a medical device company specializing in airway clearance therapy, reported record financial results for the quarter and fiscal year ended August 26, 2025. The company’s revenue rose to $17.4 million, a 17.3% increase from the same period last year, and diluted earnings per share (GAAP) reached $0.25, up from $0.20 in Q4 FY2024. These results surpassed the growth rate of the previous quarter, reflecting strong momentum in the core business. Electromed saw improvement across key profitability metrics, including a gross margin gain and significant growth in operating income. The quarter capped a strong year of operational and financial progress, though management offered no forward-looking guidance.Electromed develops and markets medical devices in the respiratory care field. Its main product is the SmartVest System, which delivers High Frequency Chest Wall Oscillation (HFCWO) therapy to help patients clear mucus from their lungs. The system is primarily used by patients suffering from chronic lung conditions such as bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and ALS.The company's business relies heavily on its direct-sales focused homecare model. Electromed’s strategy centers on sales rep productivity, expanding its reach in underpenetrated markets, and driving adoption of SmartVest through clinical education, reimbursement support, and patient outreach. Maintaining product effectiveness, regulatory compliance, and favorable reimbursement conditions are critical success factors for the company’s growth.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Nachrichten zu Q4 Inc Registered Shs Unitarymehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Q4 Inc Registered Shs Unitarymehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Electromed Inc. 24,55 0,00% Electromed Inc.